You are here

Article Text

Article menu
Download PDFPDF
Letter
Safety of 15-deoxyspergualin in the treatment of glomerulonephritis associated with active systemic lupus erythematosus

https://doi.org/10.1136/ard.2005.035329

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • PAH is an employee of Euro Nippon Kayaku, a branch of the mother company Nippon Kayaku, Tokyo, Japan, which provided the drug for this trial free of charge.

      Treatment of SLE-GN with 15-DSG was approved by the local ethics committee.